18 related articles

An in-depth analysis of AI's real-world applications in drug discovery, covering target identification, molecular generation, and protein structure prediction. Examines data quality bottlenecks, the absence of approved AI-native drugs, and pragmatic paths forward including human-AI collaboration.

Researchers use AI models to generate complete viral genome sequences never found in nature, with some designs verified as biologically active. This article analyzes the technology, applications in phage therapy and vaccines, and critical biosecurity risks.

The UK AI Safety Institute red-teamed frontier models from OpenAI and Anthropic, revealing AI successfully breached target systems. Analysis of test context, dual-use implications, and future regulation.

TextMyPill is a WhatsApp-based medication reminder tool with AI prescription recognition, requiring no app download, managing family medication schedules from one dashboard.

Google commits $40M in AI tokens and compute credits to the Genesis Mission to accelerate fundamental science. Explore the implications, opportunities, and challenges of AI-driven discovery.

How Isomorphic Labs leverages AlphaFold and cutting-edge AI to shift biosecurity from reactive response to proactive defense, building bioresilience and accelerating drug design against emerging threats.

An in-depth analysis of CBP drug interdiction operations in the San Diego area, covering behavioral detection, K-9 units, portable spectroscopy, air cargo inspection, and highway pursuit tactics.

In-depth analysis of CBP drug interdiction operations in the San Diego sector, covering behavioral recognition, K-9 units, portable spectroscopic detection, air cargo inspection, and highway pursuit techniques.

GPT-5.6 deletes files, Grok leaks codebases, DeepSeek's founder hits $36B net worth — five AI stories reveal deepening safety risks and capital concentration.

OpenAI releases the GPT-5.6 series with flagship Sol, balanced Terra, and lightweight Luna. An in-depth look at each model's positioning, use cases, pricing, and the multi-agent Ultra architecture.

Tripadvisor's AI review summaries are generating positive assessments for hotels with safety hazards while downplaying critical warnings. Deep analysis of causes and practical user protection tips.
Google Co-Scientist Explained: A Gemin…
Deep dive into Google's Co-Scientist: a Gemini-powered multi-agent AI system that autonomously generates hypotheses, conducts agent debates, and iteratively evolves research directions.
GPT-5.4 Powers a Drug Chemistry Projec…
GPT-5.4 teams with Maria AI and automated labs to complete a full drug chemistry closed loop—from literature review and hypothesis generation to experimental validation.

Anthropic's latest research shows Claude Opus 4.7 matches or surpasses dedicated NMR spectroscopy software. Explore the technical significance, drug discovery implications, and future of AI science tools.

OpenAI launches GPT-Rosalind, an enterprise AI model for life sciences. Integrating GPT-5.5 agentic coding and tool use, it covers drug discovery, molecular design, data analysis, and experimental workflows.
Product ReviewsHands-on testing of ByteDance's TRAE with Seed-2.0: three real-world challenges covering game dev, subtitle proofreading, and financial chart analysis validate its engineering-grade AI coding capabilities—completely free.
Industry InsightsAnthropic and the Gates Foundation commit $200M through grants, Claude credits, and technical support to deploy AI across global health, education, agriculture, life sciences, and economic mobility.
Tech FrontiersIsomorphic Labs, the AI drug company founded by DeepMind co-founder Hassabis, raises $2.1B. Built on AlphaFold breakthroughs, it aims to conquer all diseases.